Buda Juice, Inc. (BUDA)
AMEX AMEX Primary 
BUDA Q2 Earnings Call Highlights
BUDA NYSEAMERICAN: BUDA reported second-quarter revenue growth of 26.4% as its core beverage business expanded organically and the company began selling products in 246 Walmart stores across nine states. The company also introduced its Ultra Fresh dressings line, although startup costs associated with that business weighed on gross margin.
Buda Juice: The Optionality Isn't Mine
Buda Juice remains a 'sell,' as the current valuation at ~8x sales is unjustified given modest growth and execution risks. Country Fresh's distribution partnership offers scale, but minority shareholders face the risk of value leakage and lack of upside optionality. FY 2025 revenue reached $12.6M, well below full capacity, with gross margin contracting to 44.4% and FCF yield just over 2.3%.
Buda Juice: A Cold Chain Story With Hot IPO Expectations
Buda Juice is a newly public, founder-led organic juice company with a volatile, low-float stock and strong initial margins. BUDA's asset-light, Texas-centric model yields 31%+ EBITDA margins, but scaling nationwide risks margin compression and higher SG&A. Valuation appears stretched at ~26.6x EBITDA; fair value estimates ($6.70–$8.70) imply 15% downside from current levels.
